Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
240 studies found for:    "Parkes Weber syndrome" OR "Vascular Malformations"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Cryoablation of Venous Vascular Malformations
Condition: Venous Vascular Malformation
Intervention: Device: Percutaneous Image-guided Cryoablation (FPRPR3508 IceRod® PLUS Needles)
2 Recruiting suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Condition: Vascular Malformation
Intervention: Drug: Sirolimus
3 Not yet recruiting the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Intervention: Device: balloon assisted enteroscopy
4 Recruiting the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Interventions: Drug: Thalidomide (100mg);   Drug: Thalidomide (50mg);   Drug: placebo
5 Recruiting Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Condition: Vascular Malformations
Intervention: Drug: Sirolimus
6 Recruiting Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
7 Withdrawn Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
Conditions: Gastrointestinal Hemorrhage;   Vascular Malformation
Interventions: Drug: Thalidomide;   Drug: Placebo
8 Withdrawn Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
Conditions: Gastrointestinal Bleeding of Unknown Origin;   Gastrointestinal Vascular Malformation;   Thalidomide Efficiency
Interventions: Drug: Thalidomide;   Other: Placebo
9 Active, not recruiting Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention: Drug: Cannabidiol
10 Withdrawn Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Condition: Sturge Weber Syndrome
Intervention: Drug: Everolimus
11 Completed Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
Condition: Sturge- Weber Syndrome
Intervention: Drug: Drug: Topical Rapamycin
12 Completed Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
Condition: Sturge - Weber Syndrome (SWS)
Intervention: Other: blood sample tear drop sample
13 Completed Vascular Malformations and Abnormalities of Growth
Condition: Abnormality
Intervention: Procedure: skin biopsy
14 Completed Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers
Condition: Placenta Vascular Malformation
Intervention: Other: blood sample
15 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port-wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.
16 Completed Use of the Atkins Diet for Children With Sturge Weber Syndrome
Conditions: Epilepsy;   Sturge Weber Syndrome
Intervention: Dietary Supplement: modified Atkins diet
17 Completed Biomarker Development in Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
18 Completed Diagnosis of Hemangiomas and Vascular Malformations
Conditions: Hemangiomas;   Vascular Malformations;   Venular Malformations;   Venous Malformations;   Lymphatic Malformations;   Arteriovenous Malformations
Intervention:
19 Recruiting Bone Health in Patients With Overgrowth
Conditions: Bone Mineral Density;   Vascular Malformations
Intervention:
20 Completed Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.